- Home
- FBRX vs LXFR Comparison
FBRX vs LXFR Comparison
Compare FBRX & LXFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FBRX | LXFR |
|---|---|---|
| Founded | N/A | 1898 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 487.2M | 421.4M |
| IPO Year | 2017 | 2002 |
Fundamental Metrics
Financial Performance| Metric | FBRX | LXFR |
|---|---|---|
| Price | $22.25 | $15.85 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $67.00 | N/A |
| AVG Volume (30 Days) | ★ 194.1K | 118.7K |
| Earning Date | 05-14-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 3.65% |
| EPS Growth | ★ 61.30 | N/A |
| EPS | N/A | ★ 0.13 |
| Revenue | $36,000.00 | ★ $384,600,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.01 |
| P/E Ratio | ★ N/A | $122.15 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.78 | $10.96 |
| 52 Week High | $35.80 | $16.03 |
Technical Indicators
Market Signals| Indicator | FBRX | LXFR |
|---|---|---|
| Relative Strength Index (RSI) | 40.01 | 66.38 |
| Support Level | $10.38 | $14.74 |
| Resistance Level | $22.61 | $16.00 |
| Average True Range (ATR) | 2.22 | 0.55 |
| MACD | -0.51 | -0.02 |
| Stochastic Oscillator | 27.81 | 89.76 |
Price Performance
Historical ComparisonAbout FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.
About LXFR Luxfer Holdings PLC
Luxfer Holdings PLC is a manufacturer industrial company innovating niche applications in materials engineering. It focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean, and energy-efficient world. Luxfer's high-performance materials, components, and high-pressure gas containment devices are used in defense, first response and healthcare, transportation, and general industrial applications. It focuses on product lines related to magnesium alloys, zirconium chemicals, and carbon composites. Its segments are Elektron, Gas Cylinders, and Graphic Arts. It generates the majority of its revenue from Elektron and as well as Gas Cylinders.